Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

14
Strong Sell
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000062J1
HKD
438.60
21 (5.03%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
No of Months
12
12
12
12
Profit Before Tax
-154.00
-516.00
-659.00
-1,072.00
Adjustment
0.00
0.00
0.00
0.00
Changes In working Capital
-521.00
304.00
40.00
0.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-465.00
65.00
-318.00
-633.00
Cash Flow from Investing Activities
-891.00
-1,133.00
-37.00
-113.00
Cash Flow from Financing Activities
1,124.00
2,633.00
367.00
828.00
Net Cash Inflow / Outflow
-208.00
1,586.00
12.00
79.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
24.00
21.00
0.00
-1.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Profit Before Tax
-154.550687629788
3967.38955463598
-4,121.00
-103.90%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-521.771881966813
-1048.55102552693
527.00
50.24%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-465.966880793112
3966.6550226362
-4,431.00
-111.75%
Cash Flow from Investing Activities
-891.237419657821
-6686.31376988822
5,795.00
86.67%
Cash Flow from Financing Activities
1124.57756969856
-1105.20158385073
2,229.00
201.75%
Net Cash Inflow / Outflow
-208.464802422162
-3817.12369843519
3,609.00
94.54%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
24.1619283302103
7.73663266754827
17.00
212.31%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is -814.78% vs 120.48% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-465.97
65.19
-814.78%